The multidisciplinary program will provide comprehensive care for children with complex neuromuscular and orthopedic conditions. Physicians with the pediatric orthopedic program are also part of the ...

More than 15 million people worldwide are living with spinal cord injury (SCI), which can affect their sensory and motor ...

GOMEKLI™ is an oral, small molecule MEK inhibitor approved in the United States for the treatment of adult and pediatric patients 2 years of age and older with neurofibromatosis type 1 (NF1) who have ...